Please use this identifier to cite or link to this item: https://doi.org/10.1007/s10198-014-0664-7
DC FieldValue
dc.titleComparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD)
dc.contributor.authorYang, Fan
dc.contributor.authorLau, Titus
dc.contributor.authorLee, Evan
dc.contributor.authorVathsala, A
dc.contributor.authorChia, Kee Seng
dc.contributor.authorLuo, Nan
dc.date.accessioned2022-07-27T07:21:03Z
dc.date.available2022-07-27T07:21:03Z
dc.date.issued2015-12
dc.identifier.citationYang, Fan, Lau, Titus, Lee, Evan, Vathsala, A, Chia, Kee Seng, Luo, Nan (2015-12). Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). EUROPEAN JOURNAL OF HEALTH ECONOMICS 16 (9) : 1019-1026. ScholarBank@NUS Repository. https://doi.org/10.1007/s10198-014-0664-7
dc.identifier.issn16187598
dc.identifier.issn16187601
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/229291
dc.description.abstractObjectives: The objective of this study was to compare the performance of the 5-level EuroQol 5-dimension (EQ-5D-5L) and the Short Form 6-dimension (SF-6D) instruments in assessing patients with end-stage renal disease (ESRD) in Singapore. Methods: In a cross-sectional study, ESRD patients attending a tertiary hospital were interviewed using a battery of questionnaires including the EQ-5D-5L, the kidney disease quality of life instrument (KDQOL-36), and questions assessing dialysis history and socio-demographic characteristics. We reviewed patients’ medical records for their clinical information. We assessed the construct validity of the EQ-5D-5L and SF-6D index scores and compared their ability to distinguish between patients differing in health status and the magnitude of between-group difference they quantified. Results: One hundred and fifty ESRD patients on dialysis (mean age, 60.1 years; female, 48.7 %) participated in the study. Both EQ-5D-5L and SF-6D demonstrated satisfactory known-groups validity; the EQ-5D-5L was more sensitive to differences in clinical outcomes and the SF-6D was more sensitive to differences in health outcomes measured by KDQOL scales. The intraclass correlation coefficient between the measures was 0.36. The differences in the EQ-5D-5L index score for patients in better and worse health status were greater than those measured by the SF-6D index score. Conclusions: Both EQ-5D-5L and SF-6D are valid instruments for assessing ESRD patients. However, the two preference-based measures cannot be used interchangeably and it appears that EQ-5D-5L would lead to more favorable cost-effectiveness results than SF-6D if they are used in economic evaluations of interventions for ESRD.
dc.publisherSpringer Science and Business Media LLC
dc.sourceElements
dc.subjectESRD
dc.subjectDiscriminative ability
dc.subjectEQ-5D-5L
dc.subjectSF-6D
dc.typeArticle
dc.date.updated2022-07-22T17:13:24Z
dc.contributor.departmentDEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
dc.contributor.departmentMEDICINE
dc.contributor.departmentSAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
dc.description.doi10.1007/s10198-014-0664-7
dc.description.sourcetitleEUROPEAN JOURNAL OF HEALTH ECONOMICS
dc.description.volume16
dc.description.issue9
dc.description.page1019-1026
dc.description.placeGERMANY
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Yang2015_Article_ComparisonOfThePreference-base.pdf547.91 kBAdobe PDF

CLOSED

Published

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.